New England Journal of Medicine reported a study showing that a new antiviral therapy containing sofosbuvir over 12 weeks can eradicate HCV infection in most patients. This is a triumph of science which demonstrates the scale of painstaking and persistent effort it takes to addresss a significant healthcare problem.
To put it in perspective around 150m people, or about 3% of the world’s population, are chronically infected with the hepatitis C virus. Many of these are in their 40s and 50s and current transmission rates are low but each year that passes a proportion of those with infection progress to liver failure which is a significant cost for healthcare systems. Speaking of costs, this therapy is not cheap and has been widely reported

Vishal Gulati (I back scientists) on Twitter: “New drugs provide cure for hepatitis C, research finds http://t.co/C2M4B4uKBF / Twitter”

New drugs provide cure for hepatitis C, research finds http://t.co/C2M4B4uKBF

Source: http://www.latimes.com/science/la-sci-hepatitis-c-cure-20140412,0,3083638.story?track=rss&utm_source=dlvr.it&utm_medium=twitter#axzz30EJYv9c9